Harbin Medisan Pharmaceuticals Co., Ltd. logo

Harbin Medisan Pharmaceuticals Co., Ltd. (002900)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
14. 58
-0.25
-1.6858%
¥
4.59B Market Cap
- P/E Ratio
700% Div Yield
62.57M Volume
0 Eps
¥ 14.83
Previous Close
Add Transaction
Day Range
12.26 15.8
Year Range
8.93 16.46
Want to track 002900 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Harbin Medisan Pharmaceuticals Co., Ltd. (002900) Statistics

Valuation metrics

Market Cap 4.59B
Enterprise value 4.93B
Trailing P/E (ttm) -13.45
Forward P/E -
PEG ratio -0.5
Price/Sales (ttm) 5.24
Price/Book (mrq) 2.42
Enterprise Value/Revenue 6.07
Enterprise Value/EBITDA -27.29

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 27.42M
Average volume (90 days) 9.97M

Price summary

52-Week low 8.93
52-Week high 16.46
Beta -
50-Day moving average 10.74
200-Day moving average 11.29

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.2
Trailing annual dividend yield 0.0216%
5-Year annual dividend yield -
Payout ratio -0.27
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 13 Jun 2018

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.39%
Operating margin -0.41%

Operational effectiveness

Return on assets -0.1%
Return on equity -0.17%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 2.57
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.54
Total debt (mrq) -
Total Debt/Equity (mrq) 0.6
Current ratio (mrq) 0.88%
Book value per share (mrq) 5.59

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -